Forxiga Euroopa Liit - poola - EMA (European Medicines Agency)

forxiga

astrazeneca ab - monohydrat propanoilu dapagliflozyny - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - leki stosowane w cukrzycy - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. oprócz innych leków do leczenia cukrzycy typu 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

AuroValsart HCT 80 mg + 12,5 mg Tabletki powlekane Poola - poola - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

aurovalsart hct 80 mg + 12,5 mg tabletki powlekane

aurovitas pharma polska sp. z o.o. - valsartanum + hydrochlorothiazidum - tabletki powlekane - 80 mg + 12,5 mg

AuroValsart HCT 160 mg + 12,5 mg Tabletki powlekane Poola - poola - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

aurovalsart hct 160 mg + 12,5 mg tabletki powlekane

aurovitas pharma polska sp. z o.o. - valsartanum + hydrochlorothiazidum - tabletki powlekane - 160 mg + 12,5 mg